Virax Biolabs Group Ltd. (VRAX)

2.83 +0.10 (+3.66%) USD  |  NASDAQ  |  Sep 10, 14:58
More

Virax Biolabs Group EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for VRAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to 2025. Start Trial.
Date Value
March 31, 2026 --
Date Value
March 31, 2025 --

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Interpace Biosciences, Inc. Upgrade
Exlites Holdings International, Inc. --
Xcelerate, Inc. Upgrade
Fresenius SE & Co. KGaA Upgrade
Rafina Innovations, Inc. --